Under the TGA's new rules, the safest story is one without the patient experience

Prices paid for medicines in Australia, Japan, the United Kingdom and 16 other countries will now help set what US-based companies owe a major US government prescription medicine program.

Generic and biosimilar maker Sandoz heads 'Great Place To Work' Australia's first list of the best workplaces in biotechnology and pharmaceuticals for 2026.

In this publication's 14 years, only one organisation has answered questions with responses that its internal documents subsequently revealed reflected a decision to mislead. The TGA has been the only one, and the question concerned advertising. That same agency judges what counts as genuine news and the public interest.

The guidance cites "game-changer", alongside "life-changing" and "breakthrough", as phrases that can make media unlawful by exaggerating a medicine's efficacy. Mark Butler has used two of them. For the third, he preferred "ground-breaking".

Hayley Tamborini, Arrotex's Chief Innovation Officer and Head of Government Affairs, called the listing an important step forward for people living with the condition.

The TGA says it "does not seek to restrict genuine public‑interest journalism." Yet it has appointed itself the agency responsible for deciding what meets that test. It is an utter disgrace, and nothing less than a generational assault on free expression.

Australia's approach to newborn diagnostic testing seems very confusing. One reason cited in rejecting Pompe was the risk of 'hypervigilant' parents. Pompe is a degenerative condition where early diagnosis and treatment are critical. Yet some state-based research programs are testing for inherited high cholesterol.

Her story comes as new research commissioned by GSK Australia shows a gap between what Australians know and what they do. Many recognise how much damage shingles can cause, but few prioritise understanding their own risk.

More than 24,000 meals will reach families across New South Wales and the ACT this Christmas after staff from Biogen Australia and New Zealand spent a day packing hampers with Foodbank.

The 1946 referendum still shapes health policy, driven by long-held beliefs and an abundance of caution. Yet why is the broad application of location rules considered unconstitutional for general practice, but allowed for pharmacies? The explanation is all too simple and reflects a sentence structure with a bracketed short phrase in one place.

Patients made fewer claims than expected, and the claims they made were for smaller amounts. Pharmacies also lodged payment claims more slowly than expected.

The body representing Australia's life sciences workforce says it supports the Government's push to simplify the Research and Development Tax Incentive, but also warns that one planned change could move the regulatory and safety work behind clinical trials out of the country.

The funding comes from the latest round of the Targeted Translation Research Accelerator, which AUScelerate runs with support from the Medical Research Future Fund. Chief executive Stuart Dignam said the grants arrived as early-stage companies struggled to raise money without giving up equity.

Australians trying to quit smoking will soon be able to buy a new treatment over the pharmacy counter. It is the first new chemical entity for smoking cessation registered in Australia in almost two decades.

Hope for families and children at risk of Sanfilippo syndrome, often described as childhood dementia, with US regulatory approval of a potentially curative gene therap. Yet the critical need for early diagnosis does not exist in Australia because of the decision not to formally consider it for inclusion in newborn screening.

David Henderson, Takeda Oceania Country Head, said the vaccine gave health professionals another option when they talk to eligible travellers about preventing dengue.

The association has sought clarity on the scope of the department's AI use, the systems involved, and the safeguards applied to protected information.

A week dominated by discussions about AI that was all of good, less good, self-serving and ironic. Surely we can grasp the opportunity while managing the risks. A dehumanising outcome for women living with a form of advanced breast cancer must surely trigger ministerial intervention and another highly questionable Intergenerational Report.

In an interview with BioPharmaDispatch, Sally Panton, CEO and co-founder of Longevity Life Sciences, described a career built on a conviction in prevention and supporting well people to stay well.